Virtual ISPOR 2021
May 17-20, 2021
Program Committee
J. Jaime Caro, PhD, MDCM, FRCPC, FACP
Chief Scientist, Evidera, Adjunct Professor of Medicine, Epidemiology and Biostatistics, McGill University, Professor in Practice, London School of Economics and Political Science, Boston, MA, USA
John Hernandez, PhD
Head of Health Economics, Outcomes Research & Clinical Research Operations, Google Health, Palo Alto, CA, USA
Petra Wilson, PhD
Managing Director, Health Connect Partners, Senior Advisor for Healthcare, FTI Consulting, European Programme Director PCHA/HIMSS, Brussels, Belgium
Research Review Committee
James F. Murray, PhD
Research Fellow, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA
Anton Pottegård
Professor, Department of Public Health, University of Southern Denmark and Head of Research, Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark
Research Fellow, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA
Anton Pottegård
Professor, Department of Public Health, University of Southern Denmark and Head of Research, Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark
Janine A. Van Til, MSc
Assistant Professor, Health Technology and Services Research, University of Twente, Enschede, The Netherlands
R. Brett McQueen, MA, PhD
University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver, CO, USA
Assistant Professor, Health Technology and Services Research, University of Twente, Enschede, The Netherlands
R. Brett McQueen, MA, PhD
University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver, CO, USA
Issue Panel/Workshop Review Committee
Blythe Adamson, PhD, MPH
Director, Quantitative Sciences, Flatiron Health, New York, USA
Jon Campbell, PhD
Senior Vice President, Health Economics, ICER, Boston, MA, USA
Bruce Crawford, MA, MPH
Vice President, Real World & Late Phase, APAC, Syneos Health, Tokyo, Japan
Gregory Daniel, PhD, MPH
Head, U. S. Healthcare Policy, Edwards Lifesciences, Washington, DC, USA
Ratna Devi, MBBS, MBA
CEO and Co-founder, Board member, DakshamA Health and Education, New Delhi, India, Chair, International Alliance of Patients’ Organizations, London, UK
Director, Quantitative Sciences, Flatiron Health, New York, USA
Jon Campbell, PhD
Senior Vice President, Health Economics, ICER, Boston, MA, USA
Bruce Crawford, MA, MPH
Vice President, Real World & Late Phase, APAC, Syneos Health, Tokyo, Japan
Gregory Daniel, PhD, MPH
Head, U. S. Healthcare Policy, Edwards Lifesciences, Washington, DC, USA
Ratna Devi, MBBS, MBA
CEO and Co-founder, Board member, DakshamA Health and Education, New Delhi, India, Chair, International Alliance of Patients’ Organizations, London, UK
Juan Marcos Gonzalez, PhD
Assistant Professor, Department of Population Health Sciences, Duke University, Durham, NC, USA
Emelie Heintz, PhD
Health Economist, Researcher, Center for Health Economics, Informatics and Health Services Research (CHIS), Region Stockholm, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden
Michelle Mujoomdar, PhD
Director, Scientific Affairs, CADTH, Ottawa, ON, Canada
Assistant Professor, Department of Population Health Sciences, Duke University, Durham, NC, USA
Emelie Heintz, PhD
Health Economist, Researcher, Center for Health Economics, Informatics and Health Services Research (CHIS), Region Stockholm, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden
Michelle Mujoomdar, PhD
Director, Scientific Affairs, CADTH, Ottawa, ON, Canada